Gilead starts two late-stage studies to test drug for coronavirus
Companies, agencies, institutions, etc
Reuters
All Rights Reserved
People
Trisha Roy
Arun KoyyurAll
Groups
Asian
Physical locations
No matching tags
Places
No matching tags
Locations
Bengaluru
Events
No matching tags
Summary
Gilead Sciences Inc said on Wednesday it has started two late-stage studies to test its drug in patients with coronavirus.
As said here by Reuters Editorial